The likelihood of approval (LoA) of Chengdu Kanghong Pharmaceuticals’ (SHE:002773) Phase III conbercept in neovascular age-related macular degeneration (AMD) dropped…
As of 31 March, the likelihood of approval (LoA) for Ionis Pharmaceuticals’ IONIS-PKK-LRx (donidalorsen sodium) for hereditary angioedema (HAE) rose 8…
Bharat Biotech is all set to commence clinical trials of the third dose of its Covid-19 vaccine, Covaxin, as a booster dose six months after…
A joint venture between DemeRx and Atai Life Sciences has been cleared by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to start enrolment…
On 1 March, Merck announced the voluntary withdrawal of its Keytruda (pembrolizumab) immunotherapy for the treatment of patients with metastatic…
Clinical stage pharmaceutical development firm Algernon Pharmaceuticals is seeking ethics approval in Australia for its planned multinational Phase IIb/III study…
Zhittya Genesis Medicine has secured regulatory approval from Mexico's governing body COFEPRIS to test its drug in people with Parkinson's…
Abeona Therapeutics is ready to initiate its pivotal Phase III clinical trial, VIITAL, to evaluate EB-101 for the treatment of…
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
The likelihood of approval (LoA) for AMO Pharma’s AMO-01 in Phelan-McDermid Syndrome (PMS) with co-morbid epilepsy jumped 13 points as of 29…
Relief Therapeutics’ RLF-100 (aviptadil) received an 11-point boost in its likelihood of approval (LoA) as of 30 March, after the…
Organoids can be defined as a 3D culture of heterogenous cells that self-organise and function in a similar way to…
Strategikon Pharma announced a global update for its Clinical Maestro™ platform that advances capabilities for tracking out of scope services…
To facilitate virtual TMF inspections and improve efficiency, the European Medicines Agency (EMA) encourages sponsors to provide inspectors direct system…
